What it's actually good for
N-acetylcysteine (NAC) is a modified form of the amino acid cysteine, valued less for what it does directly than for what it becomes: the rate-limiting precursor to glutathione, the body's primary intracellular antioxidant. That mechanism has decades of clinical use behind it, not just supplement-industry marketing. Intravenous NAC is the standard antidote for acetaminophen (paracetamol) overdose — it works by replenishing hepatic glutathione before a toxic acetaminophen metabolite can destroy the liver, a use so well established it's now unremarkable in hospital medicine. Orally, NAC has the longest track record as a mucolytic, prescribed across Europe for decades to loosen mucus and cut exacerbation frequency in chronic bronchitis and COPD. Everything else NAC is sold for — general antioxidant support, kidney protection during contrast-dye procedures, immune and psychiatric applications — sits on a thinner, more mixed evidence base.
What the research says
Liver and respiratory protection (Grade B). A 2000 systematic review by Stey et al. in the European Respiratory Journal, pooling 11 randomized trials and just over 2,000 chronic bronchitis patients, found oral NAC nearly halved the exacerbation-free failure rate versus placebo — 48.5% of NAC patients had no exacerbation compared with 31.2% on placebo, with no increase in adverse effects. Later, larger single trials split on dose: the 2014 PANTHEON trial (Zheng et al., Lancet Respiratory Medicine) found 600 mg twice daily cut annual COPD exacerbations by 22% in over 1,000 patients, while the earlier BRONCUS trial (Decramer et al., Lancet, 2005), using half that dose, found no significant benefit over three years. Combined with its role as the acetaminophen-overdose antidote, this is where NAC's evidence is strongest — a B rather than an A because the effective dose and which patients benefit most are still unsettled.
Antioxidant and anti-inflammatory effects (Grade B). As a glutathione precursor, NAC reliably raises glutathione levels and lowers oxidative-stress markers in human trials — the mechanism itself is well characterized. Translating that into a specific downstream benefit is where results get inconsistent. A 2013 meta-analysis of 10 RCTs (Sun et al., PLoS ONE) testing IV NAC to prevent contrast-induced kidney injury found only a nonsignificant trend toward benefit and called the evidence "too inconsistent... to warrant a conclusion on efficacy" — a fair summary of NAC's broader antioxidant story: plausible mechanism, real biomarker changes, unreliable clinical payoff outside the lung and liver.
How much, and which form
600-1,800 mg/day, split into two or three doses, covers the range used in most respiratory and antioxidant trials. Pharmaceutical-grade NAC — the same molecule used in prescription mucolytics — is widely available over the counter. Taking it on an empty stomach improves absorption but is more likely to trigger NAC's most common side effect, mild GI upset; splitting doses or taking it with food is a reasonable trade for tolerability.
Safety & interactions
NAC has one of the longer safety records of any supplement, backed by decades of use as an approved drug in IV and inhaled form. Inhaled (nebulized) NAC can trigger bronchospasm in people with asthma — a risk that doesn't carry over to oral capsules. It may blunt nitroglycerin's blood-pressure-lowering effect, and activated charcoal can reduce its oral absorption if taken together; the concern about it interfering with chemotherapy is theoretical and the evidence is mixed. The FDA has periodically questioned NAC's dietary-supplement status because it was approved as a drug first, though it remains widely sold. This is informational, not medical advice — check with a clinician before starting, especially if pregnant, nursing, or on medication.
How we picked the brand
An NAC product earns a spot when it's pharmaceutical-grade N-acetylcysteine with no unnecessary additives, states dose clearly per capsule, and passes independent third-party testing (NSF Certified for Sport or equivalent).